Tabakman, Rinat <br/><br/>
Nerve growth factor pretreatment attenuates oxygen and glucose deprivation-induced c-Jun amino-terminal kinase 1 and stress-activated kinases p38alpha and p38beta activation and confers neuroprotection in the pheochromocytoma PC12 Model.  [electronic resource] 

 -  Journal of molecular neuroscience : MN  2004 
 - 237-50 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>0895-8696 
<br/><br/><label>Standard No.: </label>10.1385/jmn:22:3:237  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Brain Ischemia--drug therapy<br/>Caspase 3<br/>Caspases--metabolism<br/>Cell Hypoxia--drug effects<br/>Enzyme Activation--drug effects<br/>Glucose--deficiency<br/>Isoenzymes--antagonists & inhibitors<br/>JNK Mitogen-Activated Protein Kinases<br/>L-Lactate Dehydrogenase--metabolism<br/>Mitogen-Activated Protein Kinase 1--drug effects<br/>Mitogen-Activated Protein Kinase 11<br/>Mitogen-Activated Protein Kinase 14<br/>Mitogen-Activated Protein Kinases--antagonists & inhibitors<br/>Models, Biological<br/>Nerve Growth Factor--pharmacology<br/>Neuroprotective Agents--pharmacology<br/>PC12 Cells<br/>Rats<br/>Reperfusion Injury--drug therapy<br/>p38 Mitogen-Activated Protein Kinases